The numbers of K19+ cholangiocytes, myeloperoxidase (MPO)-expressing neutrophils, and αSMA+ HSCs, and liver fibrosis (Sirius red staining) were significantly lower in C33-treated mice relative to vehicle-treated mice (Fig. 8D, E). The gene discussed is KRT19; the disease is Hepatic fibrosis.